http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004014291-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb17664ddb144fb04e8ce49e954ef55a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B68B1-06 |
| filingDate | 2002-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91d41b7586e21883f646167d1620cf61 |
| publicationDate | 2004-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2004014291-A3 |
| titleOfInvention | Use of methylnaltrexone in treating gastrointestinal dysfunction in equines |
| abstract | Systems and methods are described for using methylnaltrexone in treating inhibition of gastrointestinal motility in equines. A method for preventing and treating opioid-induced and non-opioid-induced gastrointestinal dysfunction includes administering a quaternary derivative of noroxymorphone to an equine before or after the onset of the gastrointestinal dysfunction. |
| priorityDate | 2002-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.